Monthly Archives: November 2020
Controversial COVID-19 Drug Administered at Pennsylvania Nursing Home
A Pennsylvania nursing home recently came under fire after it was discovered that the facility had administered hydroxychloroquine to residents battling COVID-19, without first obtaining approval to conduct an experimental treatment. Although touted by some as being a legitimate treatment for COVID-19, the FDA recently warned against the use of hydroxychloroquine in non-hospital settings… Read More »
The Physical Loss Requirement of COVID-19 Business Interruption Claims
As long as a virus exclusion is not included in a company’s business interruption policy, most disputes arising from COVID-19-related claims will depend on whether a claimant can prove that the closure of a business property (due to contamination or threatened contamination), qualifies as physical loss or damage. This could prove to be an… Read More »
Were Coronavirus Nursing Home Deaths Preventable?
While the coronavirus has affected the health of millions of people, certain individuals have proven to be at an especially high risk of contracting the virus. For instance, the New York Times reports that while only seven percent of U.S. COVID-19 cases have occurred in long-term care facilities, deaths in these same facilities account… Read More »
Federal and State Agencies Launch Investigations into Pennsylvania Nursing Homes
Recently, FBI investigators and officials from the Attorney General’s office raided two Pennsylvania nursing homes where hundreds of residents and employees had tested positive for COVID-19. Both nursing homes in question are located in the Pittsburgh area, operated by the same company, and accused of neglect, fraud, and abuse, especially in regards to violations… Read More »
